Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,699,146
-$2,569,690 QoQ
Shares Held
2,725
-50.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#546
of 1,322 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$311,770
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Game Creek Capital, LP holds $1,699,146 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,725 | $1,699,146 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,699,146 | 2,725 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $311,770 | 500 | Put | Sole | 2026-08-13 | |
| 2026-03-31 | $772,640 | 1,000 | Put | Sole | 2026-05-14 | |
| 2026-03-31 | $4,268,836 | 5,525 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,510,723 | 8,435 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,769,179 | 4,925 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,614,375 | 3,075 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||